Genetic clusteringof KPC-2-producing carbapenem-resistant Klebsiella pneumoniae ST5422-KL19 in Shanghai, China Authors: Yinjuan Guo, Yongpeng Shang, Weihua Han, Haojin Gao, Bingjie Wang, Ying Zhou, Fangyou Yu Published: 2026 ABSTRACT Abstract The globally disseminated high-risk CRKP clone ST5422, though frequently harboring multiple carbapenemase genes, exhibits only sporadic occurrence in China. We report a Shanghai genetic clustering involving seven ST5422 CRKP isolates harboring blaKPC-2. Comprehensive characterization through antimicrobial susceptibility testing, whole-genome sequencing, phylogenetic reconstruction, and virulence/fitness assessments revealed all strains co-harbored blaCTX-M-15 with homogeneous resistance profiles: high-level resistance to carbapenems, ceftazidime/avibactam, and tigecycline, while maintaining susceptibility to colistin and amikacin. Phylogenetic analysis of all 13 ST5422 strains available in NCBI resolved three distinct clades. Subsequent characterization revealed that our clinical isolates exhibited significantly enhanced virulence and antimicrobial resistance relative to these reference strains. ST5422 isolates showed a higher virulence and certain adaptability compared with NUTH-K2044 and HS11286 (ST11). We conclude that localized dissemination of ST5422 CRKP carrying blaKPC-2 in China constitutes a significant public health concern requiring coordinated containment strategies. Importance K. pneumoniae is one of the most relevant opportunistic pathogens and causes various human infections. CRKP is not only known for its resistance to various antibiotics but also for the emergence of highly virulent strains. ST11 CRKP is the dominant clone, accounting for 60% of CRKP infections in China, while ST5422 is a single locus variant of ST11. A clear understanding of the evolutionary trajectory of this clone is imperative for the formulation of effective containment strategies. The significance of our research is that the seven KPC-2-producing ST5422 isolates exhibited high-level resistance to carbapenems, tigecycline, and ceftazidime-avibactam, and certain adaptability to the environment, phylogenetically closest to China.Supplementary InformationThe online version contains supplementary material available at 10.1186/s12866-026-05151-z. Introduction Klebsiella pneumoniae, particularly carbapenem-resistant K. pneumoniae (CRKP), has emerged as a global public health threat [1–3]. These pathogens cause colonization and severe infections, especially bloodstream-associated infections, respiratory tract infections, and urinary tract infections, with high mortality [4, 5]. The detection rate of CRKP has steadily increased from 6.4% in 2014 to 10.8% in 2023, according to the China Antimicrobial Resistance Surveillance System (http://www.carss.cn/). China Antimicrobial Surveillance Network (CHINET) reports that the resistance rate to imipenem and meropenem has continuously increased from 3.0% and 2.9% in 2005 to 22.6% and 23.4% in 2024 [6]. Highly resistant and highly virulent K. pneumoniae (CR-hvKP) spreads globally, causing serious harm and is difficult to treat. The World Health Organization (WHO) reported that the the detection rate of CR-hvKP continues to increase. The most frequent endemic sequence type (ST) of CRKP in the United States is 258 [2], while ST11 is predominant in Asia [7, 8]. Both lineages belong to clonal group 258. ST258, a high-risk CRKP line, is responsible for its global distribution, prevalence, and the rapid dissemination of various determinants of antibiotic resistance [9]. There are numerous reports of hypervirulent and multidrug-resistant K. pneumoniae from China in the last few years. Clinical isolates of ST11 clones exhibiting concurrent carbapenem resistance and enhanced virulence have been documented with increasing frequency. This trend gained particular attention following the lethal nosocomial outbreak that occurred in China during 2016 [10]. The process of increasing ST diversity involves gene mutations at the single-nucleotide level, as well as the acquisition or loss of auxiliary genes such as antibiotic resistance genes, exacerbating the outbreak and prevalence of CRKP. Another important factor is the presence of a wide range of virulence factors. During infection, CRKP expresses a diverse range of virulence factors, such as the capsular polysaccharide, lipopolysaccharide, pili, and siderophore (including yersiniabactin ybt, colibactin clb, pVir-encoded aerobactin iuc, and salmochelin iro), etc. Moreover, controlling CR-hvKP is complicated by its multiple serotypes. Unlike other Enterobacteriaceae, CRKP is distinguished by a thick capsule composed of viscous polysaccharides. Currently, at least 82 capsular types (K types) of K. pneumoniae have been identified, among which K1, K2, K5, K20, K54, and K57 were the dominant K types of highly virulent K. pneumoniae. K47 and K64 K types accounted for more than 76% of CRKPs in China [11]. Sharma et al. found that one ST5422 isolate harboring blaKPC-2 and blaNDM genes was a single locus variant of ST11 [12]. The emergence of evolutionarily convergent ST11 strains, which combine hypervirulence traits with multidrug resistance and efficient plasmid-mediated dissemination, poses a growing public health concern [13]. ST5422 CRKP strains have remained sporadic and have rarely been detected in China. A recent study found that IMP-1-producing ST5422 K. pneumoniae isolated from sputum were also reported in China [14]. However, the ST5422 CRKP clone is rarely associated with the production of KPC-2 in China, apart from the 10 strains (from 5 patients) reported recently [15]. Evidence of virulence and adaptability between ST5422 and other clones remains lacking. Thus, it is imperative to investigate the characteristics of ST5422 CRKP. In this work, we evaluated the detection of KPC-producing CRKP ST5422 isolates in China. Furthermore, we conducted an analysis of the molecular characteristics of ST5422 isolates and undertook a comparative assessment of the virulence and fitness exhibited by ST5422 and ST11 clones. Method and materials Ethics statement This study was approved by the Ethics Committee of Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai, China (K25—152Y). Individual patients or their legal guardians provided informed consent. Organism identification We collected 7 unique CRKP isolates from 72 CRKP strains in a teaching hospital in Shanghai, China, between Oct 2023 and Feb 2024. These patients ranged in age from 62 to 78 years old, and all had clinical diagnoses, including lung disease accompanied by esophageal cancer and cervical disc herniation. Organism identification was completed using the matrix-assisted desorption ionization-time of flight mass spectrometry (bioMérieux, France). K. pneumoniae strain HS11286 (cKp, ST11) was used as a virulence-negative control strain, and NTUH-K2044 (hvKP, ST23-KL1) was used as a virulence-positive control strain. All isolates were maintained in broth containing 40% glycerol and stored at − 80 °C. Authority of NTUH-K2044 by Jin-Town Wang from National Taiwan University Hospital. Antimicrobial susceptibility testing Antimicrobial susceptibility testing was performed by the Vitek II system (bioMérieux, France) according to the Clinical and Laboratory Standards Institute (CLSI 2025) guidelines [16]. The Escherichia coli ATCC 25922 and E. coli ATCC 35218 were as quality control strains for drug susceptibility testing. The K. pneumoniae that is resistant to meropenem or imipenem (breakpoint was susceptible ≤ 1 μg/mL and resistant ≥ 4 μg/mL) is defined as CRKP. Whole-genomic sequencing (WGS) and bioinformatic analysis To prepare libraries for whole-genome sequencing, frozen stocks were plated onto tryptic soy agar supplemented with 5% sheep blood. Genomic DNA was extracted utilizing standard protocols (QIAamp DNA Mini Kit, Qiagen, Germany), followed by the preparation of libraries in accordance with the manufacturer's instructions and sequenced using an Illumina NovaSeq 6000 platform with 2 × 125—bp paired-end reads. We assembled and annotated draft genomes utilizing SPAdes (version 3.12) and PROKKA (Proksee—Genome Analysis) software as described previously [17, 18]. After quality control (completeness and contamination checks), low-quality and contaminated genomes (> 5%) were excluded. The final high-quality dataset comprised genomes ranging from 5.2 to 5.7 Mbp with N50 value greater than 100,000, suitable for downstream analysis. WGS data for all isolates were analyzed using Kleborate (GitHub—klebgenomics/Kleborate), Resfinder, AMRFinder, Virulence factors, and PlasmidFinder database (Center for Genomic Epidemiology (dtu.dk)) to determine MLST, serotype, capsular type, resistance, and virulence genes. (https://genomicepidemiology.org/). Phylogeny visualization To construct a phylogenetic tree, the 7 ST5422 CRKP strains from this study (PRJNA:1,393,864) were compared with global ST5422 isolates. Core-genome relatedness was assessed using Pathogenwatch. Pairwise distances were computed from substitution differences across shared core loci after applying the platform’s variation filter; indels were excluded, and distances were scaled to an expected core size. A distance matrix was used to infer a neighbour-joining dendrogram (R package ape), which was midpoint rooted (R package phangorn). The software environment used in Fig. 1 is as follows: R (v4.3.0) with ggplot2 (v3.4.2) [19], ggtree (v3.8.0) [20], ape (v5.7.1) [21], phangorn (v2.11.1) [22], cowplot (v1.1.1), patchwork (v1.1.2), and tidyverse (v2.0.0). Fig. 1Phylogenetic tree. Comparison of the virulence (a) and resistance genes (b) of 7 ST5422 CRKP isolates in this study and other 13 ST5422 strains Phylogenetic tree. Comparison of the virulence (a) and resistance genes (b) of 7 ST5422 CRKP isolates in this study and other 13 ST5422 strains Growth curve assay First, sterile culture broth is dispensed into a multi-well plate. Wells are inoculated with a standardized CRKP suspension, leaving blanks for control. The loaded plate is immediately placed into the pre-warmed (37 °C) instrument. The program is set to continuously shake the plate and measure Optical Density (OD) at 600 nm for each well at frequent, user-defined intervals (every 30 min) over 24 h. The instrument automatically records OD values versus time. Software then compiles the data, plotting the real-time growth curve (lag, exponential, and stationary phases) without manual sampling. String test and biofilm formation assay A positive string test for hypermucoviscosity is defined as the formation of a viscous filament longer than 5 mm when a K. pneumoniae colony is stretched with a bacteriological loop on an agar plate [23]. Static biofilm production was assessed in 96-well flat-bottom polystyrene microtiter plates using crystal violet staining, following previously established protocols [24]. After staining, images were captured for visual documentation, and biofilm formation was quantified by measuring the optical density at 595 nm using a microplate reader. The chrome azurol S (CAS) assay The chrome azurol S (CAS) assay was performed following established protocols to assess the iron-chelating capabilities of CRKP supernatants as previously described [25]. Briefly, bacteria (1μL of 1 × 107 CFU/mL concentrate) were inoculated into CAS medium and cultured overnight. The size of the circles was compared to determine the production of siderophores. Capsular polysaccharide quantification assay Quantify the content of KP capsule polysaccharides by measuring the content of uronic acid (UA) as previously mentioned [26]. Nine strains were cultured overnight to OD600, then treated with Zwittergent 3–14 (50 °C, 20 min) and centrifuged. Supernatant was precipitated with ethanol, air-dried, and resuspended. Uronic acid was detected via borate-sulfuric acid and hydroxyphenyl reagent at OD520, quantified by a standard curve, and normalized to OD600. Serum killing assay Since the experimental method using a ratio of 1 to 3 of bacteria and serum exceeded the lower limit of detection, we made improvements based on this method [27]. In brief, 100 ul of bacterial suspension containing 1.0 × 106 CFU/mL was mixed with 100 ul of healthy human serum and incubated at 37 °C. The 0 and 3-h incubation mixtures were diluted with saline, spread on MH plates, and cultured overnight. The number of inoculated bacteria was calculated, and the survival curve of serum sensitivity was drawn. Infection of Galleria mellonella larvae Galleria mellonella larvae with a weight of 150–200 mg were stored in the dark at 4 °C until use. The turbidity of the suspension of actively growing bacteria was adjusted to a turbidity standard of 0.5 McFarland (1 × 108 CFU/ml) units using 0.9% NaCl. After surface disinfection with 75% ethanol, 10 μl of the bacterial suspension (containing approximately 1 × 107 CFU/ml) was injected into the last left foreleg of the larva using a syringe. A group of 10 larvae was injected simultaneously with 10 μl of 0.9% NaCl to ensure that death was not due to injection trauma. Ten larvae per group were placed in a 14—cm sterile Petri dish and maintained at 37 °C in the dark. Larvae were considered dead if they showed no movement when gently poked with a cotton swab. Larvae were examined for pigmentation, and the time of death was recorded. Three independent experiments were performed. Statistics Statistical significance (P < 0.05) was assessed using a two-tailed Student's t-test or log-rank (Mantel–Cox) test, performed with GraphPad Prism 9. Results Antimicrobial susceptibility testing and resistome characterization Antimicrobial susceptibility testing results were summarized in Table 1. All 7 strains, resistant to 15 antibiotics, had almost identical antibacterial susceptibility profiles. All 7 strains belonged to CRKP.Table 1K-locus, multi-locus sequence typing, and antimicrobial susceptibility results of the ST5422 KPC-2-producing CRKP isolatesIsolatesST typeK/O typeTZPCAZCTXFEPIMPMEMAKTOBCIPLEVTGCCSSXTCZAERA(KB)C10ST5422KL19/O2 > 128 > 64 > 64 > 32 > 16 > 16 > 64 > 16 > 4 > 832 < 0.5 > 32032/827C17ST5422KL19/O2 > 128 > 64 > 64 > 32 > 16 > 164 > 16 > 4 > 832 < 0.5 > 32032/829C24ST5422KL19/O2 > 128 > 64 > 64 > 32 > 16 > 164 > 16 > 4 > 864 < 0.5 > 32032/827C25ST5422KL19/O2 > 128 > 64 > 64 > 32 > 16 > 164 > 16 > 4 > 832 < 0.5 < 2032/827C32ST5422KL19/O2 > 128 > 64 > 64 > 32 > 16 > 168 > 16 > 4 > 864 < 0.5 > 32032/827C103ST5422KL19/O2 > 128 > 64 > 64 > 32 > 16 > 168 > 16 > 4 > 8322 > 32032/825C303ST5422KL19/O2 > 128 > 64 > 64 > 32 > 16 > 164 > 16 > 4 > 864 < 0.5 > 32032/827NTUH-K2044ST23KL1 > 12832 > 64 > 32 > 16 > 16 > 64 > 16 > 4412 > 3200.5/0.12528HS11286ST11 > 12832 > 64 > 322 > 16 > 64 > 16 > 44 < 0.5 < 0.5 > 3204/427TZP Piperacillin-tazobactam, CAZ Ceftazidime, CTX Cefotaxime, FEP Cefepime, IMP Imipenem, MEM Meropenem, AK Amikacin, TOB CIP, Ciprofloxacin, LEV Levofloxacin, TGC Tigecycline, CS Polymyxin B, SXT Sulfamethoxazole, CZA Ceftazidime-avibactam, ERA Eravacycline Table 1K-locus, multi-locus sequence typing, and antimicrobial susceptibility results of the ST5422 KPC-2-producing CRKP isolatesIsolatesST typeK/O typeTZPCAZCTXFEPIMPMEMAKTOBCIPLEVTGCCSSXTCZAERA(KB)C10ST5422KL19/O2 > 128 > 64 > 64 > 32 > 16 > 16 > 64 > 16 > 4 > 832 < 0.5 > 32032/827C17ST5422KL19/O2 > 128 > 64 > 64 > 32 > 16 > 164 > 16 > 4 > 832 < 0.5 > 32032/829C24ST5422KL19/O2 > 128 > 64 > 64 > 32 > 16 > 164 > 16 > 4 > 864 < 0.5 > 32032/827C25ST5422KL19/O2 > 128 > 64 > 64 > 32 > 16 > 164 > 16 > 4 > 832 < 0.5 < 2032/827C32ST5422KL19/O2 > 128 > 64 > 64 > 32 > 16 > 168 > 16 > 4 > 864 < 0.5 > 32032/827C103ST5422KL19/O2 > 128 > 64 > 64 > 32 > 16 > 168 > 16 > 4 > 8322 > 32032/825C303ST5422KL19/O2 > 128 > 64 > 64 > 32 > 16 > 164 > 16 > 4 > 864 < 0.5 > 32032/827NTUH-K2044ST23KL1 > 12832 > 64 > 32 > 16 > 16 > 64 > 16 > 4412 > 3200.5/0.12528HS11286ST11 > 12832 > 64 > 322 > 16 > 64 > 16 > 44 < 0.5 < 0.5 > 3204/427TZP Piperacillin-tazobactam, CAZ Ceftazidime, CTX Cefotaxime, FEP Cefepime, IMP Imipenem, MEM Meropenem, AK Amikacin, TOB CIP, Ciprofloxacin, LEV Levofloxacin, TGC Tigecycline, CS Polymyxin B, SXT Sulfamethoxazole, CZA Ceftazidime-avibactam, ERA Eravacycline K-locus, multi-locus sequence typing, and antimicrobial susceptibility results of the ST5422 KPC-2-producing CRKP isolates TZP Piperacillin-tazobactam, CAZ Ceftazidime, CTX Cefotaxime, FEP Cefepime, IMP Imipenem, MEM Meropenem, AK Amikacin, TOB CIP, Ciprofloxacin, LEV Levofloxacin, TGC Tigecycline, CS Polymyxin B, SXT Sulfamethoxazole, CZA Ceftazidime-avibactam, ERA Eravacycline A number of antimicrobial resistance genes, including qnrS1, sul1, sul2, tet(A), dfrA14, aadA2, rmtB, gyrA, parC, blaLAP-2, and blaTEM-141, were detected in 7 CRKP ST5422 isolates, suggesting that multidrug resistance was preserved in the ST5422 clone (Fig. 1A). There were 2 genes (including blaCTX-M-65 and blaKPC-2) associated with β-lactam antibiotics in 7 CRKP isolates. blaSHV-12 was present in 6 of the CRKP. High-level resistance to fluoroquinolones, characterized by ciprofloxacin resistance exceeding 4 mg/L and levofloxacin resistance exceeding 8 mg/L, is associated with triple mutations in the quinolone resistance-determining regions, gyrA and parC. Specifically, these mutations involve amino acid changes from S83 to I and D87 to G in GyrA, and from S80 to I in ParC. The aadA2 and rmtB conferred higher-level resistance to aminoglycoside antibiotics (tobramycin). However, none of the 7 strains of CRKP had the AAC(6’) gene detected, and 6 of them were sensitive to amikacin. WGS data analysis revealed that the presence of the blaKPC-2 gene was confirmed by WGS in all CRKP strains displaying resistance to carbapenems and CAZ/AVI. In addition, the ompK35 gene of the 7 CRKP ST5422 isolates remained intact (Fig. 1B), and known mutations associated with resistance to cephalosporins or carbapenems were identified with the OmpK36 GD protein. Resistance to tigecycline was observed in all seven CRKP strains, whereas susceptibility to eravacycline was noted. Furthermore, the tet(A) gene was detected in every strain. The results of the WGS analysis showed that acrR was detected with a 43% mutation rate. We used PCR to verify that the acrR gene had mutations, which were possibly related to resistance to tigecycline. Molecular typing and phylogenetic analysis All CRKP isolates belonged to ST5422. The KL19-O2 serotype associated with wzi allele 19 was inferred in all ST5422-KPC CRKP isolates. As shown in Table 2, Proksee identified the four key junction modules: oriT, relaxase, TC4P, and T4SS. While oriT sites were detected in only three of the seven CRKP strains, notably, none possessed a T4SS. The 7 CRKP strains carried the same plasmid replicons, including ColRNAI, IncFIB(pKPHS1), IncFII(pHN7A8),IncFII(pSDP9R), IncHI1B(pNDM-MAR),IncN4, IncR,and repB (Table 2).Table 2Four key junction modules and plasmids of 7 ST5422 CRKP strainsStrainsoriT regionRelaxaseT4CPT4SSColRNAIIncFIB(pKPHS1)IncFII(pHN7A8)IncFII(pSDP9R)IncHI1B(pNDM-MAR)IncN4IncRrepBC1035,962..35989 (+)-415,957..418695 (+)- + + + + + + + + C1744,524..44551 (-)490,733..491167 (+)2124..4862 (-)- + + + + + + + + C2444,524..44551 (-)490,733..491167 (+)2124..4862 (-)- + + + + + + + + C2544,524..44551 (-)151,520..151954 (-)-- + + + + + + + + C3235,962..35989 (+)490,733..491167 (+)2124..4862 (-)- + + + + + + + + C10335,962..35989 (+)-15,665..19846 (+)- + + + + + + + + C30344,818..44845 (-)439,395..439829 (+)-- + + + + + + + + Table 2Four key junction modules and plasmids of 7 ST5422 CRKP strainsStrainsoriT regionRelaxaseT4CPT4SSColRNAIIncFIB(pKPHS1)IncFII(pHN7A8)IncFII(pSDP9R)IncHI1B(pNDM-MAR)IncN4IncRrepBC1035,962..35989 (+)-415,957..418695 (+)- + + + + + + + + C1744,524..44551 (-)490,733..491167 (+)2124..4862 (-)- + + + + + + + + C2444,524..44551 (-)490,733..491167 (+)2124..4862 (-)- + + + + + + + + C2544,524..44551 (-)151,520..151954 (-)-- + + + + + + + + C3235,962..35989 (+)490,733..491167 (+)2124..4862 (-)- + + + + + + + + C10335,962..35989 (+)-15,665..19846 (+)- + + + + + + + + C30344,818..44845 (-)439,395..439829 (+)-- + + + + + + + + Four key junction modules and plasmids of 7 ST5422 CRKP strains We analyzed the WGS of 13 ST5422 K. pneumoniae strains available for download from NCBI and found that they were divided into three clusters. The results showed that these isolates were genetically closely related and all originated from China (Supplementary Fig. 1). As shown in Fig. 1A and 1B, The drug resistance genes and virulence of the ST5422 CRKP strains were similar to those from a hospital in Ruijin, Shanghai. Genome and molecular characteristics of C303 plasmids The genome consists of a circular chromosome of 5,544,888 bp and five plasmids. The resistance plasmid Plas3 was a 250,510 bp IncFII plasmid that carried the blaKPC−2 gene. Figure 2A depicts the genetic context surrounding the blaKPC-2 genes located on plasmid Plas3. Additionally, plasmid Plas3 was found to harbor multiple resistance determinants. These include the extended-spectrum β-lactamase genes blaSHV-12, blaCTX-M-65, and blaTEM-247, which explain the strain's multidrug-resistant phenotype. A BLASTn comparison of plasmid Plas3 against three reference plasmids was conducted. The bacterial strains harboring these three plasmids were all ST11-CRKP and carry the blaKPC resistance gene. It exhibited 69% query coverage (99.99% identity) with plasmid CP157363.1, 70% coverage (100% identity) with plasmid CP069172.1, and 61% coverage (100% identity) with plasmid CP154344.1. These findings indicate that while accessory elements differ, the plasmids maintain highly conserved backbone regions. In supplementary Fig. 2, blaKPC−2 was located within a conserved mobile genetic element structure composed of ISKpn27-blaKPC−2, which is commonly found on IncFII plasmids in CRKP. Fig. 2Circular map of plasmid 3 and plasmid 2 of CRKP C303. Comparative analysis of Plas3 and Plas2 plasmids with other reference plasmids. A Schematic map of plasmid Plas3. B Schematic map of plasmid Plas 2 Circular map of plasmid 3 and plasmid 2 of CRKP C303. Comparative analysis of Plas3 and Plas2 plasmids with other reference plasmids. A Schematic map of plasmid Plas3. B Schematic map of plasmid Plas 2 The virulence plasmid Plas2 was a 216,420 bp IncHI1B plasmid that carried the iutA, iutA2, and iucABCD genes (Fig. 2B). A BLASTn comparison of plasmid Plas2 against representative virulence plasmid pLVPK and two reference plasmids were conducted. The bacterial strains harboring the two plasmids were both hypervirulent K. pneumoniae. It exhibited 100% query coverage (100% identity) with plasmid CP167476.1, and 98% coverage (100% identity) with plasmid CP138524.1. Virulence-associated gene carriage in CRKP isolates All 7 isolates were negative for the string test and biofilm. ST5422-CRKP isolates had rmpA2. Salmochelin (iro) and the genotoxin colibactin (clb) were not detected in these isolates. ST5422 CRKP were all dominated by the iuc−1 lineage. Seven isolates harboured a 1LV of ybST 209 (ybt9, ICEKp3). Environmental adaptability and virulence of CRKP ST5422 As shown in supplementary Fig. 3, taking HS11286 and NTUH-K2044 as references, the results of the growth curves showed that the growth of the seven strains of ST5422 CRKP was generally slower than that of the above two strains, but there was no statistical significance. Compared with HS11286, the siderophore production of 7 CRKP strains of ST5422 increased significantly, reaching the level of NTUH-K2044 (Fig. 3A and 3B). As shown in Figs. 3C and 3D, compared to HS11286, five of the seven tested strains exhibited significantly increased uronic acid production, whereas two strains showed no statistically significant difference. Among these, three strains achieved uronic acid levels equivalent to those observed in strain NTUH-K2044. In the Galleria mellonella infection model, we selected the ST11 CRKP strain HS11286 and seven ST5422 isolates for comparative virulence assessment. We further evaluated the virulence potential of these isolates by in vitro serum resistance. The ST11 HS11286 isolate was perfectly resistant to serum killing, while the ST5422 strains showed moderate sensitivity to the serum killing agent (Fig. 3E). As shown in Fig. 3F, HS11286-infected larvae exhibited significantly lower mortality than those infected with five ST5422 strains (C24, C25, C32, C103, and C303), while showing no statistically significant difference versus larvae infected with the remaining two ST5422 CRKP isolates. Among all seven tested strains, five demonstrated mortality rates comparable to larvae infected with the hypervirulent control strain NTUH-K2044. Fig. 3Comparison of adaptability and virulence of 7 ST55422 CRKP isolate. A, B Siderophores production determined by CAS agar plate. A two-tailed Student's t-test was performed. C, D Capsular polysaccharide quantification data. A two-tailed Student's t-test was performed. E Serum killing model, the survival rates were counted at 3 h after incubation with the serum. A two-tailed Student's t-test was performed. F The survival curves of G. mellonella infected by 7 ST5422 CRKP, and 2 control strains (NTUH-K2044 and HS11286). A log-rank (Mantel-Cox) test was performed for the indicated curves.***, P < 0.001; **, P < 0.01; *, P < 0.05; ns, not significant Comparison of adaptability and virulence of 7 ST55422 CRKP isolate. A, B Siderophores production determined by CAS agar plate. A two-tailed Student's t-test was performed. C, D Capsular polysaccharide quantification data. A two-tailed Student's t-test was performed. E Serum killing model, the survival rates were counted at 3 h after incubation with the serum. A two-tailed Student's t-test was performed. F The survival curves of G. mellonella infected by 7 ST5422 CRKP, and 2 control strains (NTUH-K2044 and HS11286). A log-rank (Mantel-Cox) test was performed for the indicated curves.***, P < 0.001; **, P < 0.01; *, P < 0.05; ns, not significant Discussion ST11 CRKP poses a public health threat owing to its extensive distribution, multidrug resistance, and capacity for rapid exchange of plasmid-borne resistance determinants among other Enterobacteriaceae [8, 10, 28]. In this study, we investigated the genomic epidemiology of seven ST5422 (a single locus variant of ST11) CRKP isolates that appear to be part of an ongoing endemic lineage. ST5422 (tonB−9) is highly homologous to ST11 (tonB−4), indicating a close relationship between them; however, significant divergence exists in transmission and virulence. The seven ST5422 isolates displayed a multi-drug resistance (MDR) profile against the tested antimicrobial agents. Alternative carbapenem resistance pathways, KPC elevation, efflux upregulation, and porin loss, potentially underlie this phenomenon through compounded resistance effects. As a cornerstone therapeutic option for carbapenem-resistant Gram-negative infections, tigecycline serves as the basis of CRKP treatment regimens, typically in combination with colistin [29]. Notably, while our isolates were susceptible to eravacycline, they exhibited significant resistance to tigecycline. Whereas prior investigations observed universal tigecycline sensitivity among CRKP isolates, our results identify resistant cases [30]. Emerging CRKP resistance threatens frontline therapy, compelling reassessment of tigecycline-centered clinical protocols. Although tet(A) gene was detected in 7 ST5422 CRKP strains, functional studies must confirm their contribution to tigecycline resistance acquisition. Additionally, the current resistance mechanism of tigecycline is mainly related to overexpression of the RND efflux pump, including AcrAB encoded by the acrAB genes and the plasmid-mediated RND efflux pump (tmexCD1-toprJ1) [31]. In our study, mutations in the acrR gene were detected. The results were similar to those of a previous report, which found that of 26 tigecycline-non susceptible K. pneumoniae clinical isolates, 10 had nonsynonymous mutations in acrR [32]. In addition, blaCTX-M-65 is prevalent in ST11 isolates (28.9 to 59.61%) [33]. The blaCTX-M-65 gene was detected in all 7 ST5422 CRKP strains. K1 and K2 serotypes, approximately accounting for 70% of hvKP, were the most common hvKP capsule types and were more resistant to phagocytosis. Serotypes K1 and K2 account for about 70% of hvKp isolates and are the most common hvKp capsule types. They are usually more resistant to phagocytosis and host immune responses, so these K antigens are more virulent than other serotype strains. hvKp strains usually produce high capsules (also known as high hypermucoviscosity), which significantly increases the pathogenicity of hvKp [34]. However, the CRKP in this study was serotype K19, and 4 of the 7 strains produced similar amounts of uronic acid as NTUH-K2044, indicating that their virulence may also be comparable to NTUH-K2044. Moura et al. reported that K. pneumoniae K19 killed 100% of the larvae at 24 h post-infection (Galleria mellonella infection model), similar to the known hypermucoviscous hvKP K1 lineage [35]. Hu et al. highlighted the regional distribution bias of K-type strains, with regionally specific K-type strains, including KL19 in eastern China, which is where we are [11]. Additionally, our findings align with Hu et al. [11], who observed that the predominant seven K-types carried blaKPC-2-susceptible to CAZ/AVI but resistant to amikacin (with the exception of KL19). Five ST5422-KL14 K. pneumoniae harbouring blaIMP-1 were identified as a novel ST in China [14]. The latest study also found that strain ST5422-KL21 exhibits both high antimicrobial resistance and significant toxicity in ICU patients [15]. They reported that 5 of 10 strains of K.pneumoniae were isolated from rectal screening samples. Although these strains are resistant, they are intermediately resistant to tigecycline and sensitive to CZA, and almost none of them carry the blaCTX-M-15 resistance gene. Our strain, however, contains blaKPC-2 but is also resistant to CZA, indicating that there are other resistance mechanisms that we have not yet identified. The patients mentioned above are all from Shanghai and have a small-scale dissemination, which may be one reason why these strains have similar drug susceptibility. Additionally, through experimental validation, we confirmed the ST5422 genetic clustering strain to be highly virulent. The emergence of hypervirulent Kp has thoroughly investigated its various contributing factors, including overproduction of the capsule, the hypermucoviscous phenotype, siderophores, and other putative contributors (e.g., lipopolysaccharides, colibactin, and fimbriae) [36]. Thomas A. et al. reported that the detection of all 5 of the biomarkers iucA, iroB, peg-344, rmpA, and rmpA2 is the most accurate and pragmatic means to identify hvKp [37]. From a genetic perspective, the seven ST5422 CRKP strains in this study contain iucB, rmpA, and rmpA2. In addition to genotypic analysis, phenotypic results must also be combined to clarify the highly virulent strains. Hypermucoviscous and hypervirulent are frequently conflated terms, yet evidence confirms hypervirulence can occur without the hypermucoviscous phenotype. Despite lacking a hypermucoviscous phenotype in the string test, our seven bacterial strains produced uronic acid at levels comparable to NUTH-K2044. These findings empirically establish the high virulence of the ST5422-CRKP strains isolated in this study. The enterobactin gene is present in nearly all K. pneumoniae strains [34]. Similarly, yersiniabactin still accounts for over 90% in hvKP, but only 17—46% in cKP [34]. The siderophore yersiniabactin contributes significantly to invasive disease pathogenesis. The ybt locus, initially identified within the Yersinia high-pathogenicity island (HPI), has since been documented in multiple Enterobacteriaceae species where it resides on ICEKp elements [38]. Following the initial 2008 characterization of ICEKp1, genomic analyses have revealed 14 additional variants [39]. Critically, both cKp and hvKp strains acquire these mobile genetic elements. Notably, seven ST5422-type isolates possessed the yersiniabactin cluster (ybtSXQPAUTE, irp1, irp2, and fyuA). Yersiniabactin is one of the common virulence-related factors detected in ST11 strains, accounting for 83.80% [33]. Ybt is involved in the synthesis of the enterobactin siderophore produced by ST5422 isolates. Although the exact function of these iron utilization proteins in CRKP infections remains unclear, our data indicate that iron acquisition could be critical for ST5422 survival and persistence. In addition, despite the universal presence of four siderophore loci, Iuc demonstrates paramount importance for virulence across experimental models and constitutes a critical biomarker for high-virulence isolates [40]. The aerobactin system (iucABCD-iutA), encoded on pLVPK-type virulence plasmids, constitutes the principal virulence determinant even in strains harboring all four siderophores. Accordingly, iucA represents a robust biomarker for hvKP [41]. A limitation of this work is that the lack of clinical data from patients hampered our ability to analyze the association between CRKP strains and patient status. It does not elucidate the detailed virulence mechanism, which warrants further investigation in future studies. The specific virulence regulatory mechanisms warrant further investigation. In conclusion, our results highlight a local genetic clustering of bla-KPC2 producing ST5422-K19 CRKP, characterized by high levels of antibiotic resistance and the presence of potent resistance and virulence genes. Further work is warranted to understand why the ST5422 clone has an ability to become increasingly resistant to antibiotics and virulence, by plasmid or chromosomal mechanism. The emergence of this strain presents a formidable challenge to clinical care, making it imperative to implement enhanced vigilance, rigorous infection control protocols, and robust management strategies. Supplementary Information Supplementary Material 1. Supplementary Material 2. Supplementary Material 3. Supplementary Material 4. Supplementary Material 5. Supplementary Material 1. Supplementary Material 2. Supplementary Material 3. Supplementary Material 4. Supplementary Material 5.